US82489T1043 - Common Stock
/PRNewswire/ -- Sonder Capital, a leading healthcare venture firm focused on innovative technologies ushering in a new standard of care in medicine, announced...
We also talk with Sean Milliken, managing director of The Motley Fool Foundation’s ImpactFool (IF) Fund.
Looking beyond the headlines creates an opportunity for investors who have the patience to seek must-own overlooked stocks.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law...
SWAV stock results show that ShockWave Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ShockWave Medical (NASDAQ:SWAV) just reported results for the first quarter of ...
SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
The healthcare behemoth has fortified its dividend.
The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The value of the “global medical device market” is expected to jum...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder.
In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.
These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak.
These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating.
The company is hoping to expand, but is there enough here to attract growth investors?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina
Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina ...